Reducing Burden, Improving Continuity: A Patient Retention Case Study

Immunology trials often place a sustained burden on participants, where repeated travel to research sites becomes a major barrier that can delay recruitment, impact retention, and shape the overall study experience. MRN worked with a Sponsor to address this - integrating Home Trial Support (HTS) into a Phase 3 immunology trial. The result? By delivering over 1,300 in-home visits, the study achieved 100% patient retention during the initial 12-month period and completed recruitment exactly on schedule. These outcomes demonstrate that meeting patients where they are supports their physical well-being while also ensuring the continuity and data quality essential for complex, long-term research. Read on to learn how MRN achieved this and what the long-term retention results were.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.